Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume 9, Issue 6, Pages 1265-1271Publisher
WILEY
DOI: 10.1111/j.1600-6143.2009.02639.x
Keywords
BK virus; blood type incompatible transplantation; immunosuppression withdrawal; kidney transplantation; rejection; transplant tolerance
Categories
Funding
- US Organ Procurement and Transplantation Network
- Scientific Registry of Transplant Recipients
- NIH [5K08DK066319]
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK066319] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Rapid advances have been made in decreasing acute rejection rates and improving short-term graft survival in kidney transplant recipients. Whether these advances ultimately will lead to a commensurate improvement in long-term survival is not yet known. In recent years, greater attention has been placed on defining the precise etiology of graft loss, determining how far and with what agents we can minimize immunosuppression, and delineating the nature of both T-cell-mediated as well as antibody-mediated rejection. In addition, with the growing disparity of available organs and patients in need of a transplant, greater attention has been placed on optimizing allocation. In this minireview, we will focus on developments over the last couple of years, paying particular attention to insights, studies and observations that may attempt to elucidate some of these open questions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available